Paramount files prelim proxy for proposed SPAC acquisition of Chem Rx

NEW YORK, June 20 /PRNewswire-FirstCall/ -- Paramount Acquisition Corp. (BULLETIN BOARD: PMQC, PMQCU, PMQCW), a special purpose acquisition corporation ("SPAC"), announced the filing on June 18, 2007 of a preliminary proxy statement with the Securities and Exchange Commission (SEC) with respect to a special meeting of stockholders to be held to consider and vote upon the previously announced stock purchase agreement that provides for the acquisition of Chem Rx, a major privately-owned long-term care pharmacy based in Long Beach, New York.

Read more >>> view press release

See also >>> SPAC Talk post